FFO
SLS icon

Fortitude Family Office’s SELLAS Life Sciences SLS Stock Holding History

Fortitude Family Office’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.19K Hold
259
– – ﹤0.01% 1796
2026
Q2 		$3.82K Hold
259
– – ﹤0.01% 1204
2026
Q1 		$1.1K Buy
+259
New +$1.16K ﹤0.01% 1486

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Fortitude Family Office's SLS Position: Q3 2026 in Review

Fortitude Family Office held its SELLAS Life Sciences (SLS) position steady in Q3 2026 at 259 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Fortitude Family Office first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.82K in Q2 2026. 13 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Fortitude Family Office held 259 shares of SELLAS Life Sciences worth $3.19K as of Q3 2026.
  • Fortitude Family Office left its SELLAS Life Sciences share count unchanged in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1796 holding.
  • Fortitude Family Office first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Fortitude Family Office's SELLAS Life Sciences position peaked at $3.82K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.